T1	Participants 97 139	individuals with autism spectrum disorders
T2	Participants 788 871	DHA (n = 7) or placebo (n = 6) in 13 participants (mean age, 14.6 [SD, 5.9] years).
T3	Participants 1961 2002	individuals with autism spectrum disorder
